Protocol · Cardiovascular Health
Eisenmenger Syndrome Supportive Care Protocol
Iron is the core of this stack, with 5 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Eisenmenger Syndrome Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
6 supplements · 1 graded
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Iron | Amount listed: Based on iron studies - guided by pulmonary hypertension specialist (target ferritin >50 ng/mL) | Iron deficiency is common and worsens exercise capacity; careful supplementation may improve symptoms | Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| L-Citrulline | Amount listed: 3–6 g daily in divided doses (under specialist guidance) | Precursor to arginine and nitric oxide; may support vascular function in pulmonary hypertension
| Grade C for Blood Pressure7 studies · 25 people | |
| Coenzyme Q10 | Amount listed: 100–200 mg daily | Supports cardiac energy metabolism and has antioxidant effects | Not graded yet | |
| Vitamin D | Amount listed: 2,000–4,000 IU daily (target 40–60 ng/mL) | Deficiency common and associated with worse outcomes in pulmonary hypertension | Not graded yet | |
| Magnesium | Amount listed: 300–400 mg daily | Supports cardiac function and may help with arrhythmia prevention | Not graded yet | |
| Omega-3 Fatty Acids | Amount listed: 1–2 g EPA+DHA daily | Anti-inflammatory and cardiovascular supportive effects | Not graded yet | |
How this protocol works
In plain language
Eisenmenger syndrome is a serious complication of certain congenital heart defects. When a large hole between the heart chambers or great vessels (like a VSD or PDA) is not repaired in childhood, over time the increased blood flow to the lungs causes the pulmonary blood vessels to become damaged and stiff. Eventually, the pressure in the lungs becomes so high that blood flow reverses through the defect, causing oxygen-poor blood to mix with oxygen-rich blood. This leads to cyanosis (blue coloring), fatigue, shortness of breath, and reduced exercise capacity.
CRITICAL: Eisenmenger syndrome is a life-threatening condition that requires specialized care at a pulmonary hypertension center. Treatment includes pulmonary vasodilators (sildenafil, bosentan, prostacyclins), oxygen therapy, and careful management of complications. Heart-lung transplant may be considered. These supplements are SUPPORTIVE only and must be discussed with your cardiologist. Never start supplements without specialist approval.
Iron* deficiency is very common in Eisenmenger syndrome and pulmonary hypertension. It worsens exercise capacity and symptoms. However, iron supplementation must be carefully monitored because too much iron can also be problematic. Work with your specialist to optimize iron levels.
L-Citrulline* converts to arginine and then to nitric oxide, which relaxes blood vessels. It has been studied in pulmonary hypertension as a potential supportive therapy, though evidence is still limited.
CoQ10* supports the heart's energy production and has antioxidant effects that may help protect the stressed heart muscle.
Vitamin D* deficiency is common in pulmonary hypertension and associated with worse outcomes. Maintaining adequate levels may support overall health.
Magnesium* supports heart muscle function and may help prevent arrhythmias, which can occur in Eisenmenger syndrome.
Omega-3 Fatty Acids* have anti-inflammatory and cardiovascular supportive effects.
Expected timeline: Supplements provide supportive benefit over time. Iron supplementation (if deficient) may improve exercise capacity within weeks. This is a chronic condition requiring lifelong specialized care. The primary treatments are pharmaceutical pulmonary vasodilators.